Product news

Share this article:

Xanodyne Pharmaceuticals has received an approvable letter from the FDA for Zipsor, indicated for mild to moderate acute pain. Zipsor is an immediate release liquid-filled soft gelatin capsule containing 25 mg of diclofenac potassium, for oral administration.   

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.

Insurers get personal to nip costs

Healthcare insurers seek to curb diabetes costs with interventions that may include house calls.

Novartis dials down RNA research

The drugmaker says the therapeutic approach has a narrow treatment potential.